Fierce Healthcare
MARCH 14, 2024
Pharmaceutical costs, non-claims payments and outpatient care fueled “unchecked” healthcare spending in Massachusetts that's increasingly being felt by its residents, according to new findings from | The Bay State's healthcare cost growth benchmark program is calling for policy action after a report showed per-person health spending well (..)
Healthcare ECONOMIST
MAY 10, 2023
Today I’m turning this post over to some of my FTI colleagues in Europe ( Antoine Mialhe , Katja Murray and Valeria Fagone among others) who helped summarize the Reform of the EU pharmaceutical legislation that the European Union (EU) adopted on April 26, 2023. A more detailed analysis is in the PDF link below.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
OCTOBER 25, 2022
The proportion of pharmaceutical companies hiring for AI-related positions kept relatively steady in May 2022 compared with the equivalent month last year, according to a Pharmaceutical Technology study, with 39.3% of the companies included in the analysis recruiting for at least one such position. . Operational Challenges of AI.
Bill Of Health
APRIL 5, 2022
When we talk about microdosing psychedelics, it’s important we have a mutual understanding of its definition to be able to conduct accurate research, promote regulations, and educate the wider population. The post A Precise Definition of Microdosing Psychedelics is Needed to Promote Equitable Regulation appeared first on Bill of Health.
NASHP
OCTOBER 4, 2021
Pharmaceutical Care Management Association (PCMA) ?was The ruling affirmed that states can regulate pharmacy benefit managers (PBMs) despite PCMA’s assertion that?the?federal?Employee preempted such regulation.?The? PBM regulation is already the most common form of drug pricing-related legislation in state legislatures, and the?
Bill Of Health
NOVEMBER 18, 2022
The Truth Pill , authored by Dinesh Thakur and Prashant Reddy , is a monumental work that convincingly shows that drug regulation is but a myth in India. In their investigative style, the authors explain drug regulation in India through the lens of history, both Indian and global. By Aparajita Lath.
HIT Consultant
AUGUST 16, 2023
Accelerating the Adoption of IDMP-O to Simplify and Standardise data Assets “Fluree is a perfect fit for pharmaceutical organizations seeking to balance regulatory compliance with innovation and accelerate drug discovery, efficacy and efficiency,” said Eliud Polanco, Fluree president. years, with only a 7.9% years, with only a 7.9%
Expert insights. Personalized for you.
217 
Let's personalize your content